{"entity":{"type":"insider","cik":"0001470015","url":"/insider/0001470015","json_url":"/insider/0001470015.json","name":"Bernard Gordon R","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":78,"n_filings":14,"first":"2011-11-22","last":"2019-12-06","span_basis":"filed_date"},"name_variants":[{"name":"Bernard Gordon R","source":"filing","n_filings":14,"first_seen":"2011-11-22","last_seen":"2019-12-06"}],"transactions":[{"id":8520603,"accession":"0001209191-19-059516","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-059516","line_url":"/filing/0001209191-19-059516#line-1","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001470015","owner_name":"Bernard Gordon R","owner_display_name":"Bernard Gordon R","owner_url":"/insider/0001470015","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":4.79,"price_display":"4.79","price_state":"stated","total_value":4790.0,"total_display":"4,790.00","total_whole":"4,790","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-04","filed_date":"2019-12-06","scope":"insider"},{"id":8677384,"accession":"0001209191-19-051031","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-19-051031","line_url":"/filing/0001209191-19-051031#line-3","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001470015","owner_name":"Bernard Gordon R","owner_display_name":"Bernard Gordon R","owner_url":"/insider/0001470015","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3470.0,"shares_display":"3,470","price_per_share":5.31,"price_display":"5.31","price_state":"stated","total_value":18425.7,"total_display":"18,425.70","total_whole":"18,426","shares_owned_after":1000.0,"shares_owned_after_display":"1,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-25","filed_date":"2019-09-27","scope":"insider"},{"id":8677381,"accession":"0001209191-19-051031","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-051031","line_url":"/filing/0001209191-19-051031#line-2","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001470015","owner_name":"Bernard Gordon R","owner_display_name":"Bernard Gordon R","owner_url":"/insider/0001470015","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4400.0,"shares_display":"4,400","price_per_share":5.27,"price_display":"5.27","price_state":"stated","total_value":23188.0,"total_display":"23,188.00","total_whole":"23,188","shares_owned_after":4470.0,"shares_owned_after_display":"4,470","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-23","filed_date":"2019-09-27","scope":"insider"},{"id":8677379,"accession":"0001209191-19-051031","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-051031","line_url":"/filing/0001209191-19-051031#line-1","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001470015","owner_name":"Bernard Gordon R","owner_display_name":"Bernard Gordon R","owner_url":"/insider/0001470015","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3700.0,"shares_display":"3,700","price_per_share":5.31,"price_display":"5.31","price_state":"stated","total_value":19647.0,"total_display":"19,647.00","total_whole":"19,647","shares_owned_after":8870.0,"shares_owned_after_display":"8,870","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-20","filed_date":"2019-09-27","scope":"insider"},{"id":8320531,"accession":"0001209191-19-050361","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-19-050361","line_url":"/filing/0001209191-19-050361#line-5","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001470015","owner_name":"Bernard Gordon R","owner_display_name":"Bernard Gordon R","owner_url":"/insider/0001470015","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":5.21,"price_display":"5.21","price_state":"stated","total_value":20840.0,"total_display":"20,840.00","total_whole":"20,840","shares_owned_after":12170.0,"shares_owned_after_display":"12,170","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-19","filed_date":"2019-09-20","scope":"insider"},{"id":8320526,"accession":"0001209191-19-050361","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-19-050361","line_url":"/filing/0001209191-19-050361#line-4","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001470015","owner_name":"Bernard Gordon R","owner_display_name":"Bernard Gordon R","owner_url":"/insider/0001470015","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2987.0,"shares_display":"2,987","price_per_share":4.95,"price_display":"4.95","price_state":"stated","total_value":14785.65,"total_display":"14,785.65","total_whole":"14,786","shares_owned_after":16170.0,"shares_owned_after_display":"16,170","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-18","filed_date":"2019-09-20","scope":"insider"},{"id":8320522,"accession":"0001209191-19-050361","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-19-050361","line_url":"/filing/0001209191-19-050361#line-3","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001470015","owner_name":"Bernard Gordon R","owner_display_name":"Bernard Gordon R","owner_url":"/insider/0001470015","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":711.0,"shares_display":"711","price_per_share":4.91,"price_display":"4.91","price_state":"stated","total_value":3491.01,"total_display":"3,491.01","total_whole":"3,491","shares_owned_after":19157.0,"shares_owned_after_display":"19,157","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-17","filed_date":"2019-09-20","scope":"insider"},{"id":8320518,"accession":"0001209191-19-050361","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-050361","line_url":"/filing/0001209191-19-050361#line-2","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001470015","owner_name":"Bernard Gordon R","owner_display_name":"Bernard Gordon R","owner_url":"/insider/0001470015","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":5.05,"price_display":"5.05","price_state":"stated","total_value":505.0,"total_display":"505.00","total_whole":"505","shares_owned_after":19868.0,"shares_owned_after_display":"19,868","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-16","filed_date":"2019-09-20","scope":"insider"},{"id":8320513,"accession":"0001209191-19-050361","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-050361","line_url":"/filing/0001209191-19-050361#line-1","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001470015","owner_name":"Bernard Gordon R","owner_display_name":"Bernard Gordon R","owner_url":"/insider/0001470015","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3117.0,"shares_display":"3,117","price_per_share":5.11,"price_display":"5.11","price_state":"stated","total_value":15927.87,"total_display":"15,927.87","total_whole":"15,928","shares_owned_after":19968.0,"shares_owned_after_display":"19,968","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-13","filed_date":"2019-09-20","scope":"insider"},{"id":8206472,"accession":"0001209191-19-049507","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-19-049507","line_url":"/filing/0001209191-19-049507#line-5","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001470015","owner_name":"Bernard Gordon R","owner_display_name":"Bernard Gordon R","owner_url":"/insider/0001470015","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2646.0,"shares_display":"2,646","price_per_share":5.15,"price_display":"5.15","price_state":"stated","total_value":13626.9,"total_display":"13,626.90","total_whole":"13,627","shares_owned_after":23085.0,"shares_owned_after_display":"23,085","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-12","filed_date":"2019-09-13","scope":"insider"},{"id":8206468,"accession":"0001209191-19-049507","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-19-049507","line_url":"/filing/0001209191-19-049507#line-4","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001470015","owner_name":"Bernard Gordon R","owner_display_name":"Bernard Gordon R","owner_url":"/insider/0001470015","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2700.0,"shares_display":"2,700","price_per_share":5.01,"price_display":"5.01","price_state":"stated","total_value":13527.0,"total_display":"13,527.00","total_whole":"13,527","shares_owned_after":25731.0,"shares_owned_after_display":"25,731","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-11","filed_date":"2019-09-13","scope":"insider"},{"id":8206465,"accession":"0001209191-19-049507","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-19-049507","line_url":"/filing/0001209191-19-049507#line-3","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001470015","owner_name":"Bernard Gordon R","owner_display_name":"Bernard Gordon R","owner_url":"/insider/0001470015","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1400.0,"shares_display":"1,400","price_per_share":5.39,"price_display":"5.39","price_state":"stated","total_value":7546.0,"total_display":"7,546.00","total_whole":"7,546","shares_owned_after":28431.0,"shares_owned_after_display":"28,431","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-10","filed_date":"2019-09-13","scope":"insider"},{"id":8206462,"accession":"0001209191-19-049507","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-049507","line_url":"/filing/0001209191-19-049507#line-2","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001470015","owner_name":"Bernard Gordon R","owner_display_name":"Bernard Gordon R","owner_url":"/insider/0001470015","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2300.0,"shares_display":"2,300","price_per_share":5.24,"price_display":"5.24","price_state":"stated","total_value":12052.0,"total_display":"12,052.00","total_whole":"12,052","shares_owned_after":29831.0,"shares_owned_after_display":"29,831","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-09","filed_date":"2019-09-13","scope":"insider"},{"id":8206459,"accession":"0001209191-19-049507","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-049507","line_url":"/filing/0001209191-19-049507#line-1","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001470015","owner_name":"Bernard Gordon R","owner_display_name":"Bernard Gordon R","owner_url":"/insider/0001470015","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":4.91,"price_display":"4.91","price_state":"stated","total_value":1964.0,"total_display":"1,964.00","total_whole":"1,964","shares_owned_after":32131.0,"shares_owned_after_display":"32,131","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-06","filed_date":"2019-09-13","scope":"insider"},{"id":8120651,"accession":"0001209191-19-047851","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-19-047851","line_url":"/filing/0001209191-19-047851#line-5","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001470015","owner_name":"Bernard Gordon R","owner_display_name":"Bernard Gordon R","owner_url":"/insider/0001470015","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":900.0,"shares_display":"900","price_per_share":5.11,"price_display":"5.11","price_state":"stated","total_value":4599.0,"total_display":"4,599.00","total_whole":"4,599","shares_owned_after":32531.0,"shares_owned_after_display":"32,531","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-30","filed_date":"2019-08-30","scope":"insider"},{"id":8120647,"accession":"0001209191-19-047851","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-19-047851","line_url":"/filing/0001209191-19-047851#line-4","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001470015","owner_name":"Bernard Gordon R","owner_display_name":"Bernard Gordon R","owner_url":"/insider/0001470015","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":5.02,"price_display":"5.02","price_state":"stated","total_value":1004.0,"total_display":"1,004.00","total_whole":"1,004","shares_owned_after":33431.0,"shares_owned_after_display":"33,431","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-28","filed_date":"2019-08-30","scope":"insider"},{"id":8120641,"accession":"0001209191-19-047851","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-19-047851","line_url":"/filing/0001209191-19-047851#line-3","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001470015","owner_name":"Bernard Gordon R","owner_display_name":"Bernard Gordon R","owner_url":"/insider/0001470015","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":5.11,"price_display":"5.11","price_state":"stated","total_value":511.0,"total_display":"511.00","total_whole":"511","shares_owned_after":33631.0,"shares_owned_after_display":"33,631","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-27","filed_date":"2019-08-30","scope":"insider"},{"id":8120636,"accession":"0001209191-19-047851","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-047851","line_url":"/filing/0001209191-19-047851#line-2","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001470015","owner_name":"Bernard Gordon R","owner_display_name":"Bernard Gordon R","owner_url":"/insider/0001470015","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1400.0,"shares_display":"1,400","price_per_share":5.16,"price_display":"5.16","price_state":"stated","total_value":7224.0,"total_display":"7,224.00","total_whole":"7,224","shares_owned_after":33731.0,"shares_owned_after_display":"33,731","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-26","filed_date":"2019-08-30","scope":"insider"},{"id":8120633,"accession":"0001209191-19-047851","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-047851","line_url":"/filing/0001209191-19-047851#line-1","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001470015","owner_name":"Bernard Gordon R","owner_display_name":"Bernard Gordon R","owner_url":"/insider/0001470015","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":5.33,"price_display":"5.33","price_state":"stated","total_value":2665.0,"total_display":"2,665.00","total_whole":"2,665","shares_owned_after":35131.0,"shares_owned_after_display":"35,131","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-23","filed_date":"2019-08-30","scope":"insider"},{"id":8493110,"accession":"0001209191-19-047327","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-19-047327","line_url":"/filing/0001209191-19-047327#line-5","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001470015","owner_name":"Bernard Gordon R","owner_display_name":"Bernard Gordon R","owner_url":"/insider/0001470015","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2100.0,"shares_display":"2,100","price_per_share":5.45,"price_display":"5.45","price_state":"stated","total_value":11445.0,"total_display":"11,445.00","total_whole":"11,445","shares_owned_after":35631.0,"shares_owned_after_display":"35,631","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-21","filed_date":"2019-08-23","scope":"insider"},{"id":8493106,"accession":"0001209191-19-047327","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-19-047327","line_url":"/filing/0001209191-19-047327#line-4","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001470015","owner_name":"Bernard Gordon R","owner_display_name":"Bernard Gordon R","owner_url":"/insider/0001470015","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2631.0,"shares_display":"2,631","price_per_share":5.41,"price_display":"5.41","price_state":"stated","total_value":14233.71,"total_display":"14,233.71","total_whole":"14,234","shares_owned_after":37731.0,"shares_owned_after_display":"37,731","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-20","filed_date":"2019-08-23","scope":"insider"},{"id":8493102,"accession":"0001209191-19-047327","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-19-047327","line_url":"/filing/0001209191-19-047327#line-3","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001470015","owner_name":"Bernard Gordon R","owner_display_name":"Bernard Gordon R","owner_url":"/insider/0001470015","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":5.45,"price_display":"5.45","price_state":"stated","total_value":5450.0,"total_display":"5,450.00","total_whole":"5,450","shares_owned_after":40362.0,"shares_owned_after_display":"40,362","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-19","filed_date":"2019-08-23","scope":"insider"},{"id":8493098,"accession":"0001209191-19-047327","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-047327","line_url":"/filing/0001209191-19-047327#line-2","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001470015","owner_name":"Bernard Gordon R","owner_display_name":"Bernard Gordon R","owner_url":"/insider/0001470015","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":5.71,"price_display":"5.71","price_state":"stated","total_value":2855.0,"total_display":"2,855.00","total_whole":"2,855","shares_owned_after":41362.0,"shares_owned_after_display":"41,362","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-16","filed_date":"2019-08-23","scope":"insider"},{"id":8493093,"accession":"0001209191-19-047327","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-047327","line_url":"/filing/0001209191-19-047327#line-1","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001470015","owner_name":"Bernard Gordon R","owner_display_name":"Bernard Gordon R","owner_url":"/insider/0001470015","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":78.0,"shares_display":"78","price_per_share":5.75,"price_display":"5.75","price_state":"stated","total_value":448.5,"total_display":"448.50","total_whole":"449","shares_owned_after":41862.0,"shares_owned_after_display":"41,862","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-15","filed_date":"2019-08-23","scope":"insider"},{"id":8519251,"accession":"0001209191-19-046347","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-19-046347","line_url":"/filing/0001209191-19-046347#line-8","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001470015","owner_name":"Bernard Gordon R","owner_display_name":"Bernard Gordon R","owner_url":"/insider/0001470015","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1300.0,"shares_display":"1,300","price_per_share":5.75,"price_display":"5.75","price_state":"stated","total_value":7475.0,"total_display":"7,475.00","total_whole":"7,475","shares_owned_after":41940.0,"shares_owned_after_display":"41,940","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-13","filed_date":"2019-08-16","scope":"insider"},{"id":8519246,"accession":"0001209191-19-046347","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-19-046347","line_url":"/filing/0001209191-19-046347#line-7","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001470015","owner_name":"Bernard Gordon R","owner_display_name":"Bernard Gordon R","owner_url":"/insider/0001470015","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":900.0,"shares_display":"900","price_per_share":5.75,"price_display":"5.75","price_state":"stated","total_value":5175.0,"total_display":"5,175.00","total_whole":"5,175","shares_owned_after":43240.0,"shares_owned_after_display":"43,240","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-12","filed_date":"2019-08-16","scope":"insider"},{"id":8519243,"accession":"0001209191-19-046347","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-19-046347","line_url":"/filing/0001209191-19-046347#line-6","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001470015","owner_name":"Bernard Gordon R","owner_display_name":"Bernard Gordon R","owner_url":"/insider/0001470015","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":188.0,"shares_display":"188","price_per_share":5.79,"price_display":"5.79","price_state":"stated","total_value":1088.52,"total_display":"1,088.52","total_whole":"1,089","shares_owned_after":44140.0,"shares_owned_after_display":"44,140","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-09","filed_date":"2019-08-16","scope":"insider"},{"id":8519239,"accession":"0001209191-19-046347","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-19-046347","line_url":"/filing/0001209191-19-046347#line-5","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001470015","owner_name":"Bernard Gordon R","owner_display_name":"Bernard Gordon R","owner_url":"/insider/0001470015","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":502.0,"shares_display":"502","price_per_share":6.01,"price_display":"6.01","price_state":"stated","total_value":3017.02,"total_display":"3,017.02","total_whole":"3,017","shares_owned_after":44328.0,"shares_owned_after_display":"44,328","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-08","filed_date":"2019-08-16","scope":"insider"},{"id":8519236,"accession":"0001209191-19-046347","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-19-046347","line_url":"/filing/0001209191-19-046347#line-4","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001470015","owner_name":"Bernard Gordon R","owner_display_name":"Bernard Gordon R","owner_url":"/insider/0001470015","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":700.0,"shares_display":"700","price_per_share":5.98,"price_display":"5.98","price_state":"stated","total_value":4186.0,"total_display":"4,186.00","total_whole":"4,186","shares_owned_after":44830.0,"shares_owned_after_display":"44,830","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-07","filed_date":"2019-08-16","scope":"insider"},{"id":8519232,"accession":"0001209191-19-046347","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-19-046347","line_url":"/filing/0001209191-19-046347#line-3","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001470015","owner_name":"Bernard Gordon R","owner_display_name":"Bernard Gordon R","owner_url":"/insider/0001470015","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":6.08,"price_display":"6.08","price_state":"stated","total_value":9120.0,"total_display":"9,120.00","total_whole":"9,120","shares_owned_after":45530.0,"shares_owned_after_display":"45,530","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-05","filed_date":"2019-08-16","scope":"insider"},{"id":8519228,"accession":"0001209191-19-046347","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-046347","line_url":"/filing/0001209191-19-046347#line-2","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001470015","owner_name":"Bernard Gordon R","owner_display_name":"Bernard Gordon R","owner_url":"/insider/0001470015","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":6.07,"price_display":"6.07","price_state":"stated","total_value":2428.0,"total_display":"2,428.00","total_whole":"2,428","shares_owned_after":47030.0,"shares_owned_after_display":"47,030","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-02","filed_date":"2019-08-16","scope":"insider"},{"id":8519223,"accession":"0001209191-19-046347","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-046347","line_url":"/filing/0001209191-19-046347#line-1","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001470015","owner_name":"Bernard Gordon R","owner_display_name":"Bernard Gordon R","owner_url":"/insider/0001470015","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":800.0,"shares_display":"800","price_per_share":5.96,"price_display":"5.96","price_state":"stated","total_value":4768.0,"total_display":"4,768.00","total_whole":"4,768","shares_owned_after":47430.0,"shares_owned_after_display":"47,430","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-01","filed_date":"2019-08-16","scope":"insider"},{"id":8568148,"accession":"0001209191-19-044309","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001209191-19-044309","line_url":"/filing/0001209191-19-044309#line-9","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001470015","owner_name":"Bernard Gordon R","owner_display_name":"Bernard Gordon R","owner_url":"/insider/0001470015","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1100.0,"shares_display":"1,100","price_per_share":5.91,"price_display":"5.91","price_state":"stated","total_value":6501.0,"total_display":"6,501.00","total_whole":"6,501","shares_owned_after":48230.0,"shares_owned_after_display":"48,230","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-31","filed_date":"2019-08-02","scope":"insider"},{"id":8568144,"accession":"0001209191-19-044309","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-19-044309","line_url":"/filing/0001209191-19-044309#line-8","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001470015","owner_name":"Bernard Gordon R","owner_display_name":"Bernard Gordon R","owner_url":"/insider/0001470015","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":644.0,"shares_display":"644","price_per_share":5.81,"price_display":"5.81","price_state":"stated","total_value":3741.64,"total_display":"3,741.64","total_whole":"3,742","shares_owned_after":49330.0,"shares_owned_after_display":"49,330","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-30","filed_date":"2019-08-02","scope":"insider"},{"id":8568141,"accession":"0001209191-19-044309","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-19-044309","line_url":"/filing/0001209191-19-044309#line-7","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001470015","owner_name":"Bernard Gordon R","owner_display_name":"Bernard Gordon R","owner_url":"/insider/0001470015","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":424.0,"shares_display":"424","price_per_share":5.84,"price_display":"5.84","price_state":"stated","total_value":2476.16,"total_display":"2,476.16","total_whole":"2,476","shares_owned_after":49974.0,"shares_owned_after_display":"49,974","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-29","filed_date":"2019-08-02","scope":"insider"},{"id":8568137,"accession":"0001209191-19-044309","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-19-044309","line_url":"/filing/0001209191-19-044309#line-6","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001470015","owner_name":"Bernard Gordon R","owner_display_name":"Bernard Gordon R","owner_url":"/insider/0001470015","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":5.83,"price_display":"5.83","price_state":"stated","total_value":2915.0,"total_display":"2,915.00","total_whole":"2,915","shares_owned_after":50398.0,"shares_owned_after_display":"50,398","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-26","filed_date":"2019-08-02","scope":"insider"},{"id":8568131,"accession":"0001209191-19-044309","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-19-044309","line_url":"/filing/0001209191-19-044309#line-5","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001470015","owner_name":"Bernard Gordon R","owner_display_name":"Bernard Gordon R","owner_url":"/insider/0001470015","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":5.85,"price_display":"5.85","price_state":"stated","total_value":2925.0,"total_display":"2,925.00","total_whole":"2,925","shares_owned_after":50898.0,"shares_owned_after_display":"50,898","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-25","filed_date":"2019-08-02","scope":"insider"},{"id":8568128,"accession":"0001209191-19-044309","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-19-044309","line_url":"/filing/0001209191-19-044309#line-4","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001470015","owner_name":"Bernard Gordon R","owner_display_name":"Bernard Gordon R","owner_url":"/insider/0001470015","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":900.0,"shares_display":"900","price_per_share":5.84,"price_display":"5.84","price_state":"stated","total_value":5256.0,"total_display":"5,256.00","total_whole":"5,256","shares_owned_after":51398.0,"shares_owned_after_display":"51,398","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-24","filed_date":"2019-08-02","scope":"insider"},{"id":8568124,"accession":"0001209191-19-044309","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-19-044309","line_url":"/filing/0001209191-19-044309#line-3","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001470015","owner_name":"Bernard Gordon R","owner_display_name":"Bernard Gordon R","owner_url":"/insider/0001470015","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":5.63,"price_display":"5.63","price_state":"stated","total_value":1126.0,"total_display":"1,126.00","total_whole":"1,126","shares_owned_after":52298.0,"shares_owned_after_display":"52,298","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-22","filed_date":"2019-08-02","scope":"insider"},{"id":8568118,"accession":"0001209191-19-044309","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-044309","line_url":"/filing/0001209191-19-044309#line-2","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001470015","owner_name":"Bernard Gordon R","owner_display_name":"Bernard Gordon R","owner_url":"/insider/0001470015","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":104.0,"shares_display":"104","price_per_share":5.61,"price_display":"5.61","price_state":"stated","total_value":583.44,"total_display":"583.44","total_whole":"583","shares_owned_after":52498.0,"shares_owned_after_display":"52,498","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-19","filed_date":"2019-08-02","scope":"insider"},{"id":8568107,"accession":"0001209191-19-044309","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-044309","line_url":"/filing/0001209191-19-044309#line-1","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001470015","owner_name":"Bernard Gordon R","owner_display_name":"Bernard Gordon R","owner_url":"/insider/0001470015","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":5.69,"price_display":"5.69","price_state":"stated","total_value":2845.0,"total_display":"2,845.00","total_whole":"2,845","shares_owned_after":52602.0,"shares_owned_after_display":"52,602","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-18","filed_date":"2019-08-02","scope":"insider"},{"id":8418316,"accession":"0001209191-19-042799","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-19-042799","line_url":"/filing/0001209191-19-042799#line-5","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001470015","owner_name":"Bernard Gordon R","owner_display_name":"Bernard Gordon R","owner_url":"/insider/0001470015","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":5.64,"price_display":"5.64","price_state":"stated","total_value":5640.0,"total_display":"5,640.00","total_whole":"5,640","shares_owned_after":53102.0,"shares_owned_after_display":"53,102","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-17","filed_date":"2019-07-19","scope":"insider"},{"id":8418312,"accession":"0001209191-19-042799","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-19-042799","line_url":"/filing/0001209191-19-042799#line-4","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001470015","owner_name":"Bernard Gordon R","owner_display_name":"Bernard Gordon R","owner_url":"/insider/0001470015","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":478.0,"shares_display":"478","price_per_share":5.76,"price_display":"5.76","price_state":"stated","total_value":2753.28,"total_display":"2,753.28","total_whole":"2,753","shares_owned_after":54102.0,"shares_owned_after_display":"54,102","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-16","filed_date":"2019-07-19","scope":"insider"},{"id":8418309,"accession":"0001209191-19-042799","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-19-042799","line_url":"/filing/0001209191-19-042799#line-3","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001470015","owner_name":"Bernard Gordon R","owner_display_name":"Bernard Gordon R","owner_url":"/insider/0001470015","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2200.0,"shares_display":"2,200","price_per_share":5.69,"price_display":"5.69","price_state":"stated","total_value":12518.0,"total_display":"12,518.00","total_whole":"12,518","shares_owned_after":54580.0,"shares_owned_after_display":"54,580","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-15","filed_date":"2019-07-19","scope":"insider"},{"id":8418305,"accession":"0001209191-19-042799","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-042799","line_url":"/filing/0001209191-19-042799#line-2","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001470015","owner_name":"Bernard Gordon R","owner_display_name":"Bernard Gordon R","owner_url":"/insider/0001470015","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2893.0,"shares_display":"2,893","price_per_share":5.89,"price_display":"5.89","price_state":"stated","total_value":17039.77,"total_display":"17,039.77","total_whole":"17,040","shares_owned_after":56780.0,"shares_owned_after_display":"56,780","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-12","filed_date":"2019-07-19","scope":"insider"},{"id":8418300,"accession":"0001209191-19-042799","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-042799","line_url":"/filing/0001209191-19-042799#line-1","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001470015","owner_name":"Bernard Gordon R","owner_display_name":"Bernard Gordon R","owner_url":"/insider/0001470015","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":900.0,"shares_display":"900","price_per_share":5.74,"price_display":"5.74","price_state":"stated","total_value":5166.0,"total_display":"5,166.00","total_whole":"5,166","shares_owned_after":59673.0,"shares_owned_after_display":"59,673","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-11","filed_date":"2019-07-19","scope":"insider"},{"id":8702469,"accession":"0001209191-19-041961","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001209191-19-041961","line_url":"/filing/0001209191-19-041961#line-9","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001470015","owner_name":"Bernard Gordon R","owner_display_name":"Bernard Gordon R","owner_url":"/insider/0001470015","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2300.0,"shares_display":"2,300","price_per_share":5.9,"price_display":"5.90","price_state":"stated","total_value":13570.0,"total_display":"13,570.00","total_whole":"13,570","shares_owned_after":60573.0,"shares_owned_after_display":"60,573","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-10","filed_date":"2019-07-12","scope":"insider"},{"id":8702463,"accession":"0001209191-19-041961","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-19-041961","line_url":"/filing/0001209191-19-041961#line-8","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001470015","owner_name":"Bernard Gordon R","owner_display_name":"Bernard Gordon R","owner_url":"/insider/0001470015","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":6.11,"price_display":"6.11","price_state":"stated","total_value":3055.0,"total_display":"3,055.00","total_whole":"3,055","shares_owned_after":62873.0,"shares_owned_after_display":"62,873","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-09","filed_date":"2019-07-12","scope":"insider"},{"id":8702458,"accession":"0001209191-19-041961","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-19-041961","line_url":"/filing/0001209191-19-041961#line-7","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001470015","owner_name":"Bernard Gordon R","owner_display_name":"Bernard Gordon R","owner_url":"/insider/0001470015","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":6.25,"price_display":"6.25","price_state":"stated","total_value":2500.0,"total_display":"2,500.00","total_whole":"2,500","shares_owned_after":63373.0,"shares_owned_after_display":"63,373","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-08","filed_date":"2019-07-12","scope":"insider"},{"id":8702453,"accession":"0001209191-19-041961","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-19-041961","line_url":"/filing/0001209191-19-041961#line-6","is_derivative":false,"issuer_cik":"0001087294","issuer_name":"CUMBERLAND PHARMACEUTICALS INC","issuer_ticker":"CPIX","issuer_name_source":null,"issuer_url":"/issuer/0001087294","owner_cik":"0001470015","owner_name":"Bernard Gordon R","owner_display_name":"Bernard Gordon R","owner_url":"/insider/0001470015","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":668.0,"shares_display":"668","price_per_share":6.31,"price_display":"6.31","price_state":"stated","total_value":4215.08,"total_display":"4,215.08","total_whole":"4,215","shares_owned_after":63773.0,"shares_owned_after_display":"63,773","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-05","filed_date":"2019-07-12","scope":"insider"}],"collapsed":true,"next_cursor":"2019-07-05|8702453","ledger_fault":false,"count":{"value":78,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":78,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":78},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001087294","name":"CUMBERLAND PHARMACEUTICALS INC","url":"/issuer/0001087294","role":"Director","n_filings":14,"first_seen":"2011-11-22","last_seen":"2019-12-06"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001470015","retrieved_at":"2026-08-24T16:11:41+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}